Matthew Forsthoefel

Georgetown University, University of Pennsylvania

Papers

3

Total Citations

20

H-Index

2

About

Matthew Forsthoefel is a radiation oncologist whose research centers on optimizing prostate cancer treatment through stereotactic body radiation therapy (SBRT) and androgen deprivation therapy (ADT). His work focuses on two key areas: improving treatment precision to reduce side effects, and understanding the hormonal impacts of therapy on patient quality of life. Forsthoefel’s notable case report on utilizing the iodinated rectal spacer SpaceOAR Vue™ during robotic prostate SBRT demonstrated a novel approach to protecting the rectum in patients with MRI contraindications, earning 12 citations. He has also made significant contributions to understanding testosterone recovery kinetics after ADT and SBRT. His 2023 study on testosterone as a biomarker for quality of life (6 citations) and his 2019 work correlating testosterone recovery with improvements in patient-reported hormonal and sexual function have helped clarify the timeline and patient-specific factors affecting post-treatment recovery. These findings directly inform clinical decision-making and patient counseling. Forsthoefel’s research bridges technical innovation in radiation delivery with patient-centered outcomes, advancing both the precision and the human experience of prostate cancer treatment.

Research Focus

Key Achievements

2
H-Index
3
Papers
20
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Utilization of Iodinated SpaceOAR Vue™ During Robotic Prostate Stereotactic Body Radiation Therapy (SBRT) to Identify the Rectal–Prostate Interface and Spare the Rectum: A Case Report
12 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: Georgetown University, University of Pennsylvania

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago